181 related articles for article (PubMed ID: 32687658)
21. Inactivation of SLIT2-ROBO1/2 pathway in premalignant lesions of uterine cervix: clinical and prognostic significances.
Mitra S; Mazumder-Indra D; Mondal RK; Basu PS; Roy A; Roychoudhury S; Panda CK
PLoS One; 2012; 7(6):e38342. PubMed ID: 22719878
[TBL] [Abstract][Full Text] [Related]
22. A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.
Cullen J; Rosner IL; Brand TC; Zhang N; Tsiatis AC; Moncur J; Ali A; Chen Y; Knezevic D; Maddala T; Lawrence HJ; Febbo PG; Srivastava S; Sesterhenn IA; McLeod DG
Eur Urol; 2015 Jul; 68(1):123-31. PubMed ID: 25465337
[TBL] [Abstract][Full Text] [Related]
23. DNA methylation profiles in African American prostate cancer patients in relation to disease progression.
Rubicz R; Zhao S; Geybels M; Wright JL; Kolb S; Klotzle B; Bibikova M; Troyer D; Lance R; Ostrander EA; Feng Z; Fan JB; Stanford JL
Genomics; 2019 Jan; 111(1):10-16. PubMed ID: 26902887
[TBL] [Abstract][Full Text] [Related]
24. Genetic ancestry, self-reported race and ethnicity in African Americans and European Americans in the PCaP cohort.
Sucheston LE; Bensen JT; Xu Z; Singh PK; Preus L; Mohler JL; Su LJ; Fontham ET; Ruiz B; Smith GJ; Taylor JA
PLoS One; 2012; 7(3):e30950. PubMed ID: 22479307
[TBL] [Abstract][Full Text] [Related]
25. Association between race and oncologic outcome following radical prostatectomy for clinically organ-confined prostate cancer: a long-term follow-up study.
Amini E; Palmer TC; Cai J; Lieskovsky G; Daneshmand S; Djaladat H
World J Urol; 2018 Aug; 36(8):1233-1239. PubMed ID: 29536157
[TBL] [Abstract][Full Text] [Related]
26. Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis.
Laurin M; Huber J; Pelletier A; Houalla T; Park M; Fukui Y; Haibe-Kains B; Muller WJ; Côté JF
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7434-9. PubMed ID: 23592719
[TBL] [Abstract][Full Text] [Related]
27. Src activates Abl to augment Robo1 expression in order to promote tumor cell migration.
Khusial PR; Vadla B; Krishnan H; Ramlall TF; Shen Y; Ichikawa H; Geng JG; Goldberg GS
Oncotarget; 2010 Jul; 1(3):198-209. PubMed ID: 21301049
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the Prognostic Utility of the Cell Cycle Progression Score for Predicting Clinical Outcomes in African American and Non-African American Men with Localized Prostate Cancer.
Canter DJ; Reid J; Latsis M; Variano M; Halat S; Rajamani S; Gurtner KE; Sangale Z; Brawer M; Stone S; Bardot S
Eur Urol; 2019 Mar; 75(3):515-522. PubMed ID: 30391079
[TBL] [Abstract][Full Text] [Related]
29. Roundabout homolog 1 inhibits proliferation via the YY1-ROBO1-CCNA2-CDK2 axis in human pancreatic cancer.
Chen Q; Shen P; Ge WL; Yang TY; Wang WJ; Meng LD; Huang XM; Zhang YH; Cao SJ; Miao Y; Jiang KR; Zhang JJ
Oncogene; 2021 Apr; 40(15):2772-2784. PubMed ID: 33714986
[TBL] [Abstract][Full Text] [Related]
30. Slit2 and Robo1 induce opposing effects on metastasis of hepatocellular carcinoma Sk-hep-1 cells.
Yuan M; Guo H; Li J; Sui C; Qin Y; Wang J; Khan YH; Ye L; Xie F; Wang H; Yuan L; Ye J
Int J Oncol; 2016 Jul; 49(1):305-15. PubMed ID: 27176045
[TBL] [Abstract][Full Text] [Related]
31. Cell line modeling to study biomarker panel in prostate cancer.
NickKholgh B; Fang X; Winters SM; Raina A; Pandya KS; Gyabaah K; Fino N; Balaji KC
Prostate; 2016 Feb; 76(3):245-58. PubMed ID: 26764245
[TBL] [Abstract][Full Text] [Related]
32. Loss of miR-203 regulates cell shape and matrix adhesion through ROBO1/Rac/FAK in response to stiffness.
Le LT; Cazares O; Mouw JK; Chatterjee S; Macias H; Moran A; Ramos J; Keely PJ; Weaver VM; Hinck L
J Cell Biol; 2016 Mar; 212(6):707-19. PubMed ID: 26975850
[TBL] [Abstract][Full Text] [Related]
33. Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer.
Awasthi S; Berglund A; Abraham-Miranda J; Rounbehler RJ; Kensler K; Serna A; Vidal A; You S; Freeman MR; Davicioni E; Liu Y; Karnes RJ; Klein EA; Den RB; Trock BJ; Campbell JD; Einstein DJ; Gupta R; Balk S; Lal P; Park JY; Cleveland JL; Rebbeck TR; Freedland SJ; Yamoah K
Clin Cancer Res; 2021 Jan; 27(1):320-329. PubMed ID: 33037017
[TBL] [Abstract][Full Text] [Related]
34. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
35. Frequent alterations of SLIT2-ROBO1-CDC42 signalling pathway in breast cancer: clinicopathological correlation.
Bhattacharya R; Mukherjee N; Dasgupta H; Islam MS; Alam N; Roy A; Das P; Roychoudhury S; Panda CK
J Genet; 2016 Sep; 95(3):551-63. PubMed ID: 27659325
[TBL] [Abstract][Full Text] [Related]
36. TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence.
Zhang Q; Chen L; Helfand BT; Jang TL; Sharma V; Kozlowski J; Kuzel TM; Zhu LJ; Yang XJ; Javonovic B; Guo Y; Lonning S; Harper J; Teicher BA; Brendler C; Yu N; Catalona WJ; Lee C
PLoS One; 2011; 6(9):e25168. PubMed ID: 21980391
[TBL] [Abstract][Full Text] [Related]
37. RHOG-DOCK1-RAC1 Signaling Axis Is Perturbed in DHEA-Induced Polycystic Ovary in Rat Model.
Ubba V; Soni UK; Chadchan S; Maurya VK; Kumar V; Maurya R; Chaturvedi H; Singh R; Dwivedi A; Jha RK
Reprod Sci; 2017 May; 24(5):738-752. PubMed ID: 27662902
[TBL] [Abstract][Full Text] [Related]
38. Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.
Yuan J; Kensler KH; Hu Z; Zhang Y; Zhang T; Jiang J; Xu M; Pan Y; Long M; Montone KT; Tanyi JL; Fan Y; Zhang R; Hu X; Rebbeck TR; Zhang L
PLoS Genet; 2020 Feb; 16(2):e1008641. PubMed ID: 32059012
[TBL] [Abstract][Full Text] [Related]
39. Commercial Gene Expression Tests for Prostate Cancer Prognosis Provide Paradoxical Estimates of Race-Specific Risk.
Creed JH; Berglund AE; Rounbehler RJ; Awasthi S; Cleveland JL; Park JY; Yamoah K; Gerke TA
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):246-253. PubMed ID: 31757784
[TBL] [Abstract][Full Text] [Related]
40. Performance of the Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) tumor biomarker for identifying recurrent disease in African American patients.
Levin AM; Lindquist KJ; Avila A; Witte JS; Paris PL; Rybicki BA
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1677-82. PubMed ID: 24891551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
